{"id":"nbp607-qiv","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or erythema"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Low-grade fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"As a vaccine, NBP607-QIV works by stimulating the adaptive immune system to recognize and respond to four circulating influenza virus strains (typically two A subtypes and two B lineages). The vaccine preparation contains inactivated viral antigens that trigger antibody production and cellular immunity, enabling the immune system to mount a rapid and effective response upon exposure to wild-type influenza virus.","oneSentence":"NBP607-QIV is a quadrivalent influenza vaccine designed to provide immunological protection against four strains of influenza virus.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:22:44.290Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and/or pediatric populations"}]},"trialDetails":[{"nctId":"NCT03704740","phase":"PHASE3","title":"Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months","status":"COMPLETED","sponsor":"SK Bioscience Co., Ltd.","startDate":"2018-10-25","conditions":"Influenza","enrollment":676},{"nctId":"NCT02467842","phase":"PHASE3","title":"Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2014-10","conditions":"Influenza","enrollment":1503},{"nctId":"NCT03020628","phase":"PHASE3","title":"Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2016-10","conditions":"Influenza, Human","enrollment":171},{"nctId":"NCT02621164","phase":"PHASE3","title":"Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2014-09","conditions":"Influenza, Human","enrollment":454}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"NBP607-QIV","genericName":"NBP607-QIV","companyName":"SK Chemicals Co., Ltd.","companyId":"sk-chemicals-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"NBP607-QIV is a quadrivalent influenza vaccine designed to provide immunological protection against four strains of influenza virus. Used for Seasonal influenza prevention in adults and/or pediatric populations.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}